Jun 17, 2026 10:37AM
Jun 17, 2026 08:29AM
Jun 17, 2026 08:25AM
May 19, 2026 08:32AM
May 19, 2026 08:30AM
May 12, 2026 08:30AM
May 5, 2026 08:30AM IceCure Showcases ProSense® Cryoablation at American Society of Breast Surgeons 2026 Annual Meeting as Commercial Momentum Accelerates in the U.S. Market
Apr 21, 2026 08:30AM
Mar 25, 2026 08:30AM
Mar 24, 2026 08:31AM
Mar 24, 2026 08:30AM
Mar 17, 2026 08:30AM
Mar 11, 2026 08:30AM
Mar 11, 2026 08:30AM U.S. FDA Approves IceCure's Post-Marketing "ChoICE" Study for ProSense® Cryoablation in the Local Treatment of Low-Risk Breast Cancer
Mar 9, 2026 08:30AM
Mar 2, 2026 08:30AM
Feb 23, 2026 08:30AM
Feb 19, 2026 08:30AM
Feb 11, 2026 08:31AM
Feb 11, 2026 08:30AM
Feb 9, 2026 04:30PM IceCure Medical CFO Ronen Tsimerman to leave after nine years
Feb 9, 2026 04:30PM
Jan 28, 2026 08:30AM
Jan 12, 2026 08:31AM
Jan 12, 2026 08:30AM
Dec 17, 2025 08:30AM
Dec 10, 2025 08:31AM
Dec 10, 2025 08:30AM IceCure's ProSense® Cryoablation Featured in 4 Independent Breast Cancer Studies Presented at Radiological Society of America 2025 Annual Meeting
Dec 5, 2025 08:30AM
Dec 5, 2025 08:30AM
Nov 19, 2025 08:54AM
Nov 18, 2025 08:30AM
Nov 10, 2025 08:30AM
Nov 10, 2025 08:30AM
Nov 3, 2025 08:33AM IceCure study shows combined therapy achieves 92% lung cancer survival rate
Nov 3, 2025 08:30AM
Oct 13, 2025 08:30AM
Oct 9, 2025 08:30AM
Oct 7, 2025 06:39AM
Oct 3, 2025 12:28PM
Oct 3, 2025 12:21PM
Oct 3, 2025 12:19PM IceCure Receives FDA Marketing Authorization for ProSense® Cryoablation for the Treatment of Low-Risk Breast Cancer in Women Aged 70 and Above
Sep 15, 2025 08:31AM
Sep 15, 2025 08:30AM
Sep 4, 2025 08:30AM
Aug 15, 2025 06:53AM
Aug 13, 2025 01:58PM
Aug 13, 2025 08:30AM
Jun 25, 2025 09:24AM IceCure Medical Ltd (ICCM) Announces Record Date for Rights Offering for Up to $10 Million
Jun 25, 2025 09:23AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All